Abstract:Janus kinase (JAK) is a tyrosine kinase in cells, which plays a key role in many signal transduction pathways of cytokines involved in immunity. JAK-STAT signaling pathway is importantly engaged in cell proliferation, apoptosis, immune regulation and other processes. Currently, studies related to diseases and drug innovation are focused on inflammatory diseases and cancer which can be exemplified by inflammatory bowel disease. JAK may become a new target for the treatment of inflammatory bowel disease. This article reviews the application of small molecule Janus kinase inhibitors in inflammatory bowel disease.